{"entity":{"type":"insider","cik":"0001251512","url":"/insider/0001251512","json_url":"/insider/0001251512.json","name":"FLANAGAN ROBERT J","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":33,"n_filings":22,"first":"2004-12-23","last":"2020-03-05","span_basis":"filed_date"},"name_variants":[{"name":"FLANAGAN ROBERT J","source":"filing","n_filings":22,"first_seen":"2004-12-23","last_seen":"2020-03-05"}],"transactions":[{"id":2284978,"accession":"0001209191-20-016702","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-016702","line_url":"/filing/0001209191-20-016702#line-1","is_derivative":false,"issuer_cik":"0001025378","issuer_name":"W. P. Carey Inc.","issuer_ticker":"WPC","issuer_name_source":null,"issuer_url":"/issuer/0001025378","owner_cik":"0001251512","owner_name":"FLANAGAN ROBERT J","owner_display_name":"FLANAGAN ROBERT J","owner_url":"/insider/0001251512","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":82.29,"price_display":"82.29","price_state":"stated","total_value":82290.0,"total_display":"82,290.00","total_whole":"82,290","shares_owned_after":4717.0,"shares_owned_after_display":"4,717","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-03","filed_date":"2020-03-05","scope":"insider"},{"id":7008234,"accession":"0001181431-14-034704","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-034704","line_url":"/filing/0001181431-14-034704#line-1","is_derivative":false,"issuer_cik":"0001251512","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001251512","owner_cik":"0001251512","owner_name":"FLANAGAN ROBERT J","owner_display_name":"FLANAGAN ROBERT J","owner_url":"/insider/0001251512","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":31.99,"price_display":"31.99","price_state":"stated","total_value":255920.0,"total_display":"255,920.00","total_whole":"255,920","shares_owned_after":433770.0,"shares_owned_after_display":"433,770","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-10-22","filed_date":"2014-10-23","scope":"insider"},{"id":6585564,"accession":"0001181431-14-034077","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-034077","line_url":"/filing/0001181431-14-034077#line-2","is_derivative":false,"issuer_cik":"0001251512","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001251512","owner_cik":"0001251512","owner_name":"FLANAGAN ROBERT J","owner_display_name":"FLANAGAN ROBERT J","owner_url":"/insider/0001251512","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":31.96,"price_display":"31.96","price_state":"stated","total_value":255680.0,"total_display":"255,680.00","total_whole":"255,680","shares_owned_after":441770.0,"shares_owned_after_display":"441,770","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-10-08","filed_date":"2014-10-08","scope":"insider"},{"id":6585562,"accession":"0001181431-14-034077","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-034077","line_url":"/filing/0001181431-14-034077#line-1","is_derivative":false,"issuer_cik":"0001251512","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001251512","owner_cik":"0001251512","owner_name":"FLANAGAN ROBERT J","owner_display_name":"FLANAGAN ROBERT J","owner_url":"/insider/0001251512","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":31.15,"price_display":"31.15","price_state":"stated","total_value":249200.0,"total_display":"249,200.00","total_whole":"249,200","shares_owned_after":449770.0,"shares_owned_after_display":"449,770","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-10-07","filed_date":"2014-10-08","scope":"insider"},{"id":7008159,"accession":"0001181431-14-032640","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-032640","line_url":"/filing/0001181431-14-032640#line-2","is_derivative":false,"issuer_cik":"0001251512","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001251512","owner_cik":"0001251512","owner_name":"FLANAGAN ROBERT J","owner_display_name":"FLANAGAN ROBERT J","owner_url":"/insider/0001251512","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":29.72,"price_display":"29.72","price_state":"stated","total_value":237760.0,"total_display":"237,760.00","total_whole":"237,760","shares_owned_after":457770.0,"shares_owned_after_display":"457,770","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-09-25","filed_date":"2014-09-25","scope":"insider"},{"id":7008157,"accession":"0001181431-14-032640","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-032640","line_url":"/filing/0001181431-14-032640#line-1","is_derivative":false,"issuer_cik":"0001251512","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001251512","owner_cik":"0001251512","owner_name":"FLANAGAN ROBERT J","owner_display_name":"FLANAGAN ROBERT J","owner_url":"/insider/0001251512","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":30.3,"price_display":"30.30","price_state":"stated","total_value":242400.0,"total_display":"242,400.00","total_whole":"242,400","shares_owned_after":465770.0,"shares_owned_after_display":"465,770","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-09-24","filed_date":"2014-09-25","scope":"insider"},{"id":6786292,"accession":"0001181431-14-031877","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-031877","line_url":"/filing/0001181431-14-031877#line-2","is_derivative":false,"issuer_cik":"0001251512","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001251512","owner_cik":"0001251512","owner_name":"FLANAGAN ROBERT J","owner_display_name":"FLANAGAN ROBERT J","owner_url":"/insider/0001251512","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":28.25,"price_display":"28.25","price_state":"stated","total_value":226000.0,"total_display":"226,000.00","total_whole":"226,000","shares_owned_after":473770.0,"shares_owned_after_display":"473,770","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-09-12","filed_date":"2014-09-12","scope":"insider"},{"id":6786290,"accession":"0001181431-14-031877","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-031877","line_url":"/filing/0001181431-14-031877#line-1","is_derivative":false,"issuer_cik":"0001251512","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001251512","owner_cik":"0001251512","owner_name":"FLANAGAN ROBERT J","owner_display_name":"FLANAGAN ROBERT J","owner_url":"/insider/0001251512","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":28.35,"price_display":"28.35","price_state":"stated","total_value":226800.0,"total_display":"226,800.00","total_whole":"226,800","shares_owned_after":481770.0,"shares_owned_after_display":"481,770","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-09-11","filed_date":"2014-09-12","scope":"insider"},{"id":6673694,"accession":"0001181431-14-030578","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-030578","line_url":"/filing/0001181431-14-030578#line-2","is_derivative":false,"issuer_cik":"0001251512","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001251512","owner_cik":"0001251512","owner_name":"FLANAGAN ROBERT J","owner_display_name":"FLANAGAN ROBERT J","owner_url":"/insider/0001251512","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":27.07,"price_display":"27.07","price_state":"stated","total_value":216560.0,"total_display":"216,560.00","total_whole":"216,560","shares_owned_after":489770.0,"shares_owned_after_display":"489,770","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-08-28","filed_date":"2014-08-29","scope":"insider"},{"id":6673692,"accession":"0001181431-14-030578","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-030578","line_url":"/filing/0001181431-14-030578#line-1","is_derivative":false,"issuer_cik":"0001251512","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001251512","owner_cik":"0001251512","owner_name":"FLANAGAN ROBERT J","owner_display_name":"FLANAGAN ROBERT J","owner_url":"/insider/0001251512","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":27.3,"price_display":"27.30","price_state":"stated","total_value":218400.0,"total_display":"218,400.00","total_whole":"218,400","shares_owned_after":497770.0,"shares_owned_after_display":"497,770","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-08-27","filed_date":"2014-08-29","scope":"insider"},{"id":6553959,"accession":"0001181431-14-029057","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-029057","line_url":"/filing/0001181431-14-029057#line-2","is_derivative":false,"issuer_cik":"0001251512","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001251512","owner_cik":"0001251512","owner_name":"FLANAGAN ROBERT J","owner_display_name":"FLANAGAN ROBERT J","owner_url":"/insider/0001251512","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":24.39,"price_display":"24.39","price_state":"stated","total_value":195120.0,"total_display":"195,120.00","total_whole":"195,120","shares_owned_after":505770.0,"shares_owned_after_display":"505,770","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-08-12","filed_date":"2014-08-13","scope":"insider"},{"id":6553958,"accession":"0001181431-14-029057","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-029057","line_url":"/filing/0001181431-14-029057#line-1","is_derivative":false,"issuer_cik":"0001251512","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001251512","owner_cik":"0001251512","owner_name":"FLANAGAN ROBERT J","owner_display_name":"FLANAGAN ROBERT J","owner_url":"/insider/0001251512","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":24.39,"price_display":"24.39","price_state":"stated","total_value":195120.0,"total_display":"195,120.00","total_whole":"195,120","shares_owned_after":513770.0,"shares_owned_after_display":"513,770","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-08-11","filed_date":"2014-08-13","scope":"insider"},{"id":6436337,"accession":"0001181431-14-027891","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-027891","line_url":"/filing/0001181431-14-027891#line-2","is_derivative":false,"issuer_cik":"0001251512","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001251512","owner_cik":"0001251512","owner_name":"FLANAGAN ROBERT J","owner_display_name":"FLANAGAN ROBERT J","owner_url":"/insider/0001251512","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":25.2,"price_display":"25.20","price_state":"stated","total_value":201600.0,"total_display":"201,600.00","total_whole":"201,600","shares_owned_after":521770.0,"shares_owned_after_display":"521,770","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-07-31","filed_date":"2014-07-31","scope":"insider"},{"id":6436333,"accession":"0001181431-14-027891","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-027891","line_url":"/filing/0001181431-14-027891#line-1","is_derivative":false,"issuer_cik":"0001251512","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001251512","owner_cik":"0001251512","owner_name":"FLANAGAN ROBERT J","owner_display_name":"FLANAGAN ROBERT J","owner_url":"/insider/0001251512","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":26.0,"price_display":"26.00","price_state":"stated","total_value":208000.0,"total_display":"208,000.00","total_whole":"208,000","shares_owned_after":529770.0,"shares_owned_after_display":"529,770","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-07-30","filed_date":"2014-07-31","scope":"insider"},{"id":7007857,"accession":"0001181431-14-027062","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-027062","line_url":"/filing/0001181431-14-027062#line-2","is_derivative":false,"issuer_cik":"0001251512","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001251512","owner_cik":"0001251512","owner_name":"FLANAGAN ROBERT J","owner_display_name":"FLANAGAN ROBERT J","owner_url":"/insider/0001251512","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":26.11,"price_display":"26.11","price_state":"stated","total_value":208880.0,"total_display":"208,880.00","total_whole":"208,880","shares_owned_after":537770.0,"shares_owned_after_display":"537,770","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-07-18","filed_date":"2014-07-21","scope":"insider"},{"id":7007854,"accession":"0001181431-14-027062","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-027062","line_url":"/filing/0001181431-14-027062#line-1","is_derivative":false,"issuer_cik":"0001251512","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001251512","owner_cik":"0001251512","owner_name":"FLANAGAN ROBERT J","owner_display_name":"FLANAGAN ROBERT J","owner_url":"/insider/0001251512","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":26.25,"price_display":"26.25","price_state":"stated","total_value":210000.0,"total_display":"210,000.00","total_whole":"210,000","shares_owned_after":545770.0,"shares_owned_after_display":"545,770","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-07-17","filed_date":"2014-07-21","scope":"insider"},{"id":6462543,"accession":"0001181431-14-026046","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-026046","line_url":"/filing/0001181431-14-026046#line-2","is_derivative":false,"issuer_cik":"0001251512","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001251512","owner_cik":"0001251512","owner_name":"FLANAGAN ROBERT J","owner_display_name":"FLANAGAN ROBERT J","owner_url":"/insider/0001251512","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":26.7,"price_display":"26.70","price_state":"stated","total_value":213600.0,"total_display":"213,600.00","total_whole":"213,600","shares_owned_after":553770.0,"shares_owned_after_display":"553,770","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-07-02","filed_date":"2014-07-02","scope":"insider"},{"id":6462540,"accession":"0001181431-14-026046","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-026046","line_url":"/filing/0001181431-14-026046#line-1","is_derivative":false,"issuer_cik":"0001251512","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001251512","owner_cik":"0001251512","owner_name":"FLANAGAN ROBERT J","owner_display_name":"FLANAGAN ROBERT J","owner_url":"/insider/0001251512","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":26.31,"price_display":"26.31","price_state":"stated","total_value":210480.0,"total_display":"210,480.00","total_whole":"210,480","shares_owned_after":561770.0,"shares_owned_after_display":"561,770","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-07-01","filed_date":"2014-07-02","scope":"insider"},{"id":6584938,"accession":"0001181431-14-024416","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-024416","line_url":"/filing/0001181431-14-024416#line-2","is_derivative":false,"issuer_cik":"0001251512","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001251512","owner_cik":"0001251512","owner_name":"FLANAGAN ROBERT J","owner_display_name":"FLANAGAN ROBERT J","owner_url":"/insider/0001251512","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":23.26,"price_display":"23.26","price_state":"stated","total_value":186080.0,"total_display":"186,080.00","total_whole":"186,080","shares_owned_after":569770.0,"shares_owned_after_display":"569,770","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-06-18","filed_date":"2014-06-18","scope":"insider"},{"id":6584935,"accession":"0001181431-14-024416","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-024416","line_url":"/filing/0001181431-14-024416#line-1","is_derivative":false,"issuer_cik":"0001251512","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001251512","owner_cik":"0001251512","owner_name":"FLANAGAN ROBERT J","owner_display_name":"FLANAGAN ROBERT J","owner_url":"/insider/0001251512","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":23.47,"price_display":"23.47","price_state":"stated","total_value":187760.0,"total_display":"187,760.00","total_whole":"187,760","shares_owned_after":577770.0,"shares_owned_after_display":"577,770","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-06-17","filed_date":"2014-06-18","scope":"insider"},{"id":6285173,"accession":"0001181431-14-022751","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-022751","line_url":"/filing/0001181431-14-022751#line-2","is_derivative":false,"issuer_cik":"0001251512","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001251512","owner_cik":"0001251512","owner_name":"FLANAGAN ROBERT J","owner_display_name":"FLANAGAN ROBERT J","owner_url":"/insider/0001251512","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":22.29,"price_display":"22.29","price_state":"stated","total_value":178320.0,"total_display":"178,320.00","total_whole":"178,320","shares_owned_after":585770.0,"shares_owned_after_display":"585,770","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-06-04","filed_date":"2014-06-04","scope":"insider"},{"id":6285170,"accession":"0001181431-14-022751","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-022751","line_url":"/filing/0001181431-14-022751#line-1","is_derivative":false,"issuer_cik":"0001251512","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001251512","owner_cik":"0001251512","owner_name":"FLANAGAN ROBERT J","owner_display_name":"FLANAGAN ROBERT J","owner_url":"/insider/0001251512","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":22.05,"price_display":"22.05","price_state":"stated","total_value":176400.0,"total_display":"176,400.00","total_whole":"176,400","shares_owned_after":593770.0,"shares_owned_after_display":"593,770","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-06-03","filed_date":"2014-06-04","scope":"insider"},{"id":6581913,"accession":"0001181431-14-021012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-021012","line_url":"/filing/0001181431-14-021012#line-1","is_derivative":false,"issuer_cik":"0001251512","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001251512","owner_cik":"0001251512","owner_name":"FLANAGAN ROBERT J","owner_display_name":"FLANAGAN ROBERT J","owner_url":"/insider/0001251512","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":22.02,"price_display":"22.02","price_state":"stated","total_value":176160.0,"total_display":"176,160.00","total_whole":"176,160","shares_owned_after":601770.0,"shares_owned_after_display":"601,770","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-05-22","filed_date":"2014-05-23","scope":"insider"},{"id":5540091,"accession":"0001209191-13-044711","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-044711","line_url":"/filing/0001209191-13-044711#line-1","is_derivative":false,"issuer_cik":"0001251512","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001251512","owner_cik":"0001251512","owner_name":"FLANAGAN ROBERT J","owner_display_name":"FLANAGAN ROBERT J","owner_url":"/insider/0001251512","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500000.0,"shares_display":"500,000","price_per_share":20.0282,"price_display":"20.03","price_state":"stated","total_value":10014100.0,"total_display":"10,014,100.00","total_whole":"10,014,100","shares_owned_after":609770.0,"shares_owned_after_display":"609,770","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-09-16","filed_date":"2013-09-18","scope":"insider"},{"id":9188490,"accession":"0001181431-11-057581","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-057581","line_url":"/filing/0001181431-11-057581#line-1","is_derivative":false,"issuer_cik":"0001251512","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001251512","owner_cik":"0001251512","owner_name":"FLANAGAN ROBERT J","owner_display_name":"FLANAGAN ROBERT J","owner_url":"/insider/0001251512","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":20.18,"price_display":"20.18","price_state":"stated","total_value":20180.0,"total_display":"20,180.00","total_whole":"20,180","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-11-23","filed_date":"2011-11-23","scope":"insider"},{"id":9015247,"accession":"0001181431-11-045895","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-11-045895","line_url":"/filing/0001181431-11-045895#line-2","is_derivative":false,"issuer_cik":"0001251512","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001251512","owner_cik":"0001251512","owner_name":"FLANAGAN ROBERT J","owner_display_name":"FLANAGAN ROBERT J","owner_url":"/insider/0001251512","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":19.75,"price_display":"19.75","price_state":"stated","total_value":19750.0,"total_display":"19,750.00","total_whole":"19,750","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-08-16","filed_date":"2011-08-17","scope":"insider"},{"id":9015246,"accession":"0001181431-11-045895","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-045895","line_url":"/filing/0001181431-11-045895#line-1","is_derivative":false,"issuer_cik":"0001251512","issuer_name":"Sagent Pharmaceuticals, Inc.","issuer_ticker":"SGNT","issuer_name_source":null,"issuer_url":"/issuer/0001251512","owner_cik":"0001251512","owner_name":"FLANAGAN ROBERT J","owner_display_name":"FLANAGAN ROBERT J","owner_url":"/insider/0001251512","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":19.95,"price_display":"19.95","price_state":"stated","total_value":19950.0,"total_display":"19,950.00","total_whole":"19,950","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-08-15","filed_date":"2011-08-17","scope":"insider"},{"id":7318743,"accession":"0001355821-07-000021","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001355821-07-000021","line_url":"/filing/0001355821-07-000021#line-1","is_derivative":false,"issuer_cik":"0001251512","issuer_name":"Castle Brands Inc","issuer_ticker":"ROX","issuer_name_source":null,"issuer_url":"/issuer/0001251512","owner_cik":"0001251512","owner_name":"FLANAGAN ROBERT J","owner_display_name":"FLANAGAN ROBERT J","owner_url":"/insider/0001251512","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":167505.0,"shares_display":"167,505","price_per_share":5.97,"price_display":"5.97","price_state":"stated","total_value":1000004.85,"total_display":"1,000,004.85","total_whole":"1,000,005","shares_owned_after":167505.0,"shares_owned_after_display":"167,505","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-05-08","filed_date":"2007-05-10","scope":"insider"},{"id":3553366,"accession":"0001209191-06-049687","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-06-049687","line_url":"/filing/0001209191-06-049687#line-1","is_derivative":false,"issuer_cik":"0000892025","issuer_name":"MARTEK BIOSCIENCES CORP","issuer_ticker":"MATK","issuer_name_source":null,"issuer_url":"/issuer/0000892025","owner_cik":"0001251512","owner_name":"FLANAGAN ROBERT J","owner_display_name":"FLANAGAN ROBERT J","owner_url":"/insider/0001251512","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":21.48,"price_display":"21.48","price_state":"stated","total_value":53700.0,"total_display":"53,700.00","total_whole":"53,700","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-09-12","filed_date":"2006-09-12","scope":"insider"},{"id":3816984,"accession":"0001209191-06-049577","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-06-049577","line_url":"/filing/0001209191-06-049577#line-1","is_derivative":false,"issuer_cik":"0000892025","issuer_name":"MARTEK BIOSCIENCES CORP","issuer_ticker":"MATK","issuer_name_source":null,"issuer_url":"/issuer/0000892025","owner_cik":"0001251512","owner_name":"FLANAGAN ROBERT J","owner_display_name":"FLANAGAN ROBERT J","owner_url":"/insider/0001251512","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":20.84,"price_display":"20.84","price_state":"stated","total_value":52100.0,"total_display":"52,100.00","total_whole":"52,100","shares_owned_after":7500.0,"shares_owned_after_display":"7,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-09-11","filed_date":"2006-09-11","scope":"insider"},{"id":3750701,"accession":"0001355821-06-000038","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001355821-06-000038","line_url":"/filing/0001355821-06-000038#line-5","is_derivative":false,"issuer_cik":"0001251512","issuer_name":"Castle Brands Inc","issuer_ticker":"ROX","issuer_name_source":null,"issuer_url":"/issuer/0001251512","owner_cik":"0001251512","owner_name":"FLANAGAN ROBERT J","owner_display_name":"FLANAGAN ROBERT J","owner_url":"/insider/0001251512","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":180000.0,"total_display":"180,000.00","total_whole":"180,000","shares_owned_after":638287.0,"shares_owned_after_display":"638,287","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-04-10","filed_date":"2006-04-12","scope":"insider"},{"id":9259146,"accession":"0001209191-05-005974","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-05-005974","line_url":"/filing/0001209191-05-005974#line-1","is_derivative":false,"issuer_cik":"0000892025","issuer_name":"MARTEK BIOSCIENCES CORP","issuer_ticker":"MATK","issuer_name_source":null,"issuer_url":"/issuer/0000892025","owner_cik":"0001251512","owner_name":"FLANAGAN ROBERT J","owner_display_name":"FLANAGAN ROBERT J","owner_url":"/insider/0001251512","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":49.62,"price_display":"49.62","price_state":"stated","total_value":99240.0,"total_display":"99,240.00","total_whole":"99,240","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-12-23","filed_date":"2005-02-01","scope":"insider"},{"id":328285,"accession":"0001209191-04-059330","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-04-059330","line_url":"/filing/0001209191-04-059330#line-1","is_derivative":false,"issuer_cik":"0000892025","issuer_name":"MARTEK BIOSCIENCES CORP","issuer_ticker":"MATK","issuer_name_source":null,"issuer_url":"/issuer/0000892025","owner_cik":"0001251512","owner_name":"FLANAGAN ROBERT J","owner_display_name":"FLANAGAN ROBERT J","owner_url":"/insider/0001251512","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":49.62,"price_display":"49.62","price_state":"stated","total_value":99240.0,"total_display":"99,240.00","total_whole":"99,240","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-12-23","filed_date":"2004-12-23","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":33,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":10,"open_market":true},{"code":"S","label":"Open-market sale","n":23,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":33},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001025378","name":"W. P. Carey Inc.","url":"/issuer/0001025378","role":"Director","n_filings":1,"first_seen":"2020-03-05","last_seen":"2020-03-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001369786","name":"Sagent Pharmaceuticals, Inc.","url":"/issuer/0001369786","role":"Director","n_filings":15,"first_seen":"2011-08-17","last_seen":"2014-10-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001311538","name":"Castle Brands Inc","url":"/issuer/0001311538","role":"Director","n_filings":2,"first_seen":"2006-04-12","last_seen":"2007-05-10"},{"type":"issuer","type_label":"ISSUER","cik":"0000892025","name":"MARTEK BIOSCIENCES CORP","url":"/issuer/0000892025","role":"Director","n_filings":4,"first_seen":"2004-12-23","last_seen":"2006-09-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001251512","retrieved_at":"2026-08-25T10:21:01+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}